The antiviral activities of artemisinin and artesunate

被引:381
作者
Efferth, Thomas [1 ]
Romero, Marta R. [3 ,5 ]
Wolf, Dana G. [4 ]
Stamminger, Thomas [2 ]
Marin, Jose J. G. [5 ]
Marschall, Manfred [2 ]
机构
[1] German Canc Res Ctr, D-69120 Heidelberg, Germany
[2] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Virol, Nurnberg, Germany
[3] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London, England
[4] Hadassah Univ Hosp, Dept Clin Microbiol & Infect Dis, IL-91120 Jerusalem, Israel
[5] Univ Salamanca, Lab Expt Hepatol & Drug Targeting, CIOBERehd, E-37008 Salamanca, Spain
关键词
D O I
10.1086/591195
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Traditional Chinese medicine commands a unique position among all traditional medicines because of its 5000 years of history. Our own interest in natural products from traditional Chinese medicine was triggered in the 1990s, by artemisinin-type sesquiterpene lactones from Artemisia annua L. As demonstrated in recent years, this class of compounds has activity against malaria, cancer cells, and schistosomiasis. Interestingly, the bioactivity of artemisinin and its semisynthetic derivative artesunate is even broader and includes the inhibition of certain viruses, such as human cytomegalovirus and other members of the Herpesviridae family (e. g., herpes simplex virus type 1 and Epstein-Barr virus), hepatitis B virus, hepatitis C virus, and bovine viral diarrhea virus. Analysis of the complete profile of the pharmacological activities and molecular modes of action of artemisinin and artesunate and their performance in clinical trials will further elucidate the full antimicrobial potential of these versatile pharmacological tools from nature.
引用
收藏
页码:804 / 811
页数:8
相关论文
共 91 条
[1]  
Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8
[2]   Artemisinin antimalarials moderately affect cytochrome P450 enzyme activity in healthy subjects [J].
Asimus, Sara ;
Elsherbiny, Doaa ;
Hai, Trinh N. ;
Jansson, Britt ;
Huong, Nguyen V. ;
Petzold, Max G. ;
Simonsson, Ulrika S. H. ;
Ashton, Michael .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 (03) :307-316
[3]   WHO, the Global Fund, and medical malpractice in malaria treatment [J].
Attaran, A ;
Barnes, KI ;
Curtis, C ;
d'Alessandro, U ;
Fanello, CI ;
Galinski, MR ;
Kokwaro, G ;
Looareesuwan, S ;
Makanga, M ;
Mutabingwa, TK ;
Talisuna, A ;
Trape, JF ;
Watkins, WM .
LANCET, 2004, 363 (9404) :237-240
[4]   Structure-activity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies [J].
Avery, MA ;
Alvim-Gaston, M ;
Rodrigues, CR ;
Barreiro, EJ ;
Cohen, FE ;
Sabnis, YA ;
Woolfrey, JR .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (02) :292-303
[5]   Cytochrome P450 1A1/2 induction by antiparasitic drugs:: dose-dependent increase in ethoxyresorufin O-deethylase activity and mRNA caused by quinine, primaquine and albendazole in HepG2 cells [J].
Bapiro, TE ;
Andersson, TB ;
Otter, C ;
Hasler, JA ;
Masimirembwa, CM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (08) :537-542
[6]   Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans [J].
Bapiro, TE ;
Sayi, J ;
Hasler, JA ;
Jande, M ;
Rimoy, G ;
Masselle, A ;
Masimirembwa, CM .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (10) :755-761
[7]   ARTESUNATE - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC EFFICACY IN THE TREATMENT OF MALARIA [J].
BARRADELL, LB ;
FITTON, A .
DRUGS, 1995, 50 (04) :714-741
[8]   Hepatitis B virus mutants and fulminant hepatitis B: Fitness plus phenotype [J].
Bartholomeusz, A ;
Locarnini, S .
HEPATOLOGY, 2001, 34 (02) :432-435
[9]   Selective high-performance liquid chromatographic determination of artesunate and alpha- and beta-dihydroartemisinin in patients with falciparum malaria [J].
Batty, KT ;
Davis, TME ;
Thu, LTA ;
Binh, TQ ;
Anh, TK ;
Ilett, KF .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1996, 677 (02) :345-350
[10]   A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria [J].
Batty, KT ;
Thu, LTA ;
Davis, TME ;
Ilett, KF ;
Mai, TX ;
Hung, NC ;
Tien, NP ;
Powell, SM ;
Thien, HV ;
Binh, TQ ;
Kim, NV .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (02) :123-129